Other languages Hikma Pharmaceuticals PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:26 2024-05-01 am EDT			5-day change	1st Jan Change
1,935 ^GBX	+0.57%		+6.38%	+8.16%

Apr. 26	HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets
Apr. 25	Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	CI

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	Apr. 26
Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	Apr. 25
Hikma Pharmaceuticals backs outlook after making strong start to 2024	Apr. 25
Hikma Pharmaceuticals Affirms FY24 Guidance	Apr. 25
Hikma Pharmaceuticals PLC Proposes Final Dividend for the Full Year 2023	Apr. 25
Hikma Pharmaceuticals plc Reiterates Earnings Guidance for the Year 2024	Apr. 25
Hikma Pharmaceuticals PLC Announces Executive Changes	Apr. 15
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	Mar. 03
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	Mar. 03
Barclays cuts Direct Line to equal weight	Feb. 29
Stocks called up following slew of FTSE 100 earnings	Feb. 29
Hyloris Pharmaceuticals: le Maxigesic IV commercialisé aux Etats-unis	Feb. 28
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	Feb. 28
Merck's Bridion faces generic threat from drugmaker Hikma	Feb. 26
Barclays raises Breedon but cuts Domino's Pizza	Feb. 23
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	Feb. 22
Berenberg raises Moneysupermarket.com to 'buy'	Feb. 22
Hikma boosts dividend after year of "significant progress"	Feb. 22
Drugmaker Hikma expects profit to be slightly lower in 2024	Feb. 22
Hikma Pharmaceuticals Reports Improved FY23 Profit, Revenue	Feb. 22

No results for this search

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 06:50 am EDT